Bis(2-methoxyethyl) phthalate and REACH authorisation: what you must know

Published 
September 19, 2017

Identity of Bis(2-methoxyethyl) phthalate

Name Bis(2-methoxyethyl) phthalate IUPAC name 1,2-bis(2-methoxyethyl) benzene-1,2-dicarboxylate CAS number 117-82-8 EC number 204-212-6 Chemical formula C14H18O6

Hazard classification of Bis(2-methoxyethyl) phthalate

VERY HAZARDOUS TO HEALTH ● H350: May cause cancer
H340: May cause genetic defects
H360: May damage fertility or the unborn child
H371: May cause damage to organs
H304: May be fatal if swallowed and enters airways
H334: May cause allergy or asthma symptoms or breathing difficulties if inhaled

Bis(2-methoxyethyl) phthalate in annex XIV of REACH

Key regulatory information Intrinsic property for which it was included in Annex XIV of REACH Toxic for reproduction (category 1B) Sunset date 4 July 2020 Latest date to submit the authorisation dossier to ECHA 4 January 2019Who is concerned by REACH authorisation? Main industries concerned Polymers

EcoMundo’s advice to succeed in your authorisation application

Recommendations for your authorisation dossier

  • As the substance does not have a threshold, the Socio-Economic Analysis route will be chosen. This analysis will demonstrate that the benefits related to the granting of the authorisation outweigh the risks associated.
  • The applicant will thus have to conduct a socio-economic analysis as well as the CSR and Analysis of Alternatives.
  • The preferred methodology to conduct the socio-economic analysis of the authorisation application is the cost/benefit analysis.
  • The creation of a dossier is usually between 6 and 18 months depending on the complexity of the dossier (intrinsic properties of the substance, complexity of the applicants’ value and production chain.
  • Key elements of a successful authorisation dossier:
  • A specific request with the most elements possible in relation to your activity
  • Transparence and realism of the hypotheses and data as all elements produced will be challenged by the committees or stakeholders
  • The “applied for use” and “non-use” scenarios are essential for the relevance of the socio-economic analysis

Planning recommendations

  • The Latest Application date for this substance is 04/01/2019, the last submission window is on November 2018.
  • It is therefore recommended to start the creation of the dossier immediately (september 2017).

You want to know more on the Candidate List substances?

For more information on SVHCs, do not hesitate to contact our expert Rémi Escola on +33 9 72 26 09 56 for Europe or +1 (778) 234 1607 for North America or via email at contact@ecomundo.eu

Encore +

Articles similaires

Tous
REACH Authorization
10
/
8
/
2024

Latest Regulatory News on Chrome VI: Impact for Users

Hexavalent chromium (CrVI), identified as a carcinogenic, mutagenic and reprotoxic substance under the REACH regulation, remains widely used in industry despite its ban in Europe since 2017. The partial annulment of authorizations by the Court of Justice of the European Union has led to stricter requirements to demonstrate the absence of safe alternatives.
Biocides
9
/
30
/
2024

Biocidal Products: Labels and Claims in the EU

Biocidal products are substances designed to control harmful organisms through chemical or biological means. The regulatory framework governing these products in the EU is primarily based on Regulation (EU) No. 528/2012 (BPR), which outlines the requirements for placing these products on the market, including strict rules on labelling and claims. This article summarizes key points from a recent webinar on the subject, covering the regulatory landscape, labelling requirements, and best practices for making compliant claims.
Cosmetics
9
/
11
/
2024

Understanding the Regulation of Cosmetic Ingredients in Europe: 5 Key Facts

The regulation of cosmetic ingredients in the European Union (EU) is stringent and designed to ensure consumer safety. Cosmetic ingredients are regulated under the EU Cosmetic Product Regulation EU 1223/2009, where ingredients of concern are categorized as prohibited, restricted, or authorized substances, primarily outlined in Annexes II to VI.